(Redirected from Hyperinsulinemia)
Jump to: navigation, search

For patient information click here

ICD-10 E15, E16.1
ICD-9 251.1
DiseasesDB 20590
MeSH D006946

WikiDoc Resources for Hyperinsulinism


Most recent articles on Hyperinsulinism

Most cited articles on Hyperinsulinism

Review articles on Hyperinsulinism

Articles on Hyperinsulinism in N Eng J Med, Lancet, BMJ


Powerpoint slides on Hyperinsulinism

Images of Hyperinsulinism

Photos of Hyperinsulinism

Podcasts & MP3s on Hyperinsulinism

Videos on Hyperinsulinism

Evidence Based Medicine

Cochrane Collaboration on Hyperinsulinism

Bandolier on Hyperinsulinism

TRIP on Hyperinsulinism

Clinical Trials

Ongoing Trials on Hyperinsulinism at Clinical Trials.gov

Trial results on Hyperinsulinism

Clinical Trials on Hyperinsulinism at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hyperinsulinism

NICE Guidance on Hyperinsulinism


FDA on Hyperinsulinism

CDC on Hyperinsulinism


Books on Hyperinsulinism


Hyperinsulinism in the news

Be alerted to news on Hyperinsulinism

News trends on Hyperinsulinism


Blogs on Hyperinsulinism


Definitions of Hyperinsulinism

Patient Resources / Community

Patient resources on Hyperinsulinism

Discussion groups on Hyperinsulinism

Patient Handouts on Hyperinsulinism

Directions to Hospitals Treating Hyperinsulinism

Risk calculators and risk factors for Hyperinsulinism

Healthcare Provider Resources

Symptoms of Hyperinsulinism

Causes & Risk Factors for Hyperinsulinism

Diagnostic studies for Hyperinsulinism

Treatment of Hyperinsulinism

Continuing Medical Education (CME)

CME Programs on Hyperinsulinism


Hyperinsulinism en Espanol

Hyperinsulinism en Francais


Hyperinsulinism in the Marketplace

Patents on Hyperinsulinism

Experimental / Informatics

List of terms related to Hyperinsulinism

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Hyperinsulinism or hyperinsulinemia refers to an above normal level of insulin in the blood of a person or animal. Normal insulin secretion and blood levels are closely related to the level of glucose in the blood, so that a given level of insulin can be normal for one blood glucose level but low or high for another. Hyperinsulinism can be associated with several types of medical problems, which can be roughly divided into two broad categories: those tending toward reduced sensitivity to insulin and high blood glucose levels (hyperglycemia), and those tending toward excessive insulin secretion and low glucose levels (hypoglycemia).

Hyperinsulinism due to diminished sensitivity, associated with diabetes risk

Although many factors influence insulin secretion, the most important control is the amount of glucose moving from the blood into the beta cells of the pancreas. In healthy people, even small rises in blood glucose result in increased insulin secretion. As long as the pancreatic beta cells are able to sense the glucose level and produce insulin, the amount of insulin secreted is usually the amount required to maintain a fasting blood glucose between 70 and 100 mg/dL (3.9-5.6 mmol/L) and a non-fasting glucose level below 140 mg/dL (<7.8 mmol/L).

When liver cells and others that remove glucose from the blood become less sensitive and more resistant to the insulin, the pancreas increases secretion and the level of insulin in the blood rises. This increased secretion can compensate for reduced sensitivity for many years, with maintenance of normal glucose levels. However, if insulin resistance worsens or insulin secretion ability declines, the glucose levels will begin to rise. Persistent elevation of glucose levels is termed diabetes mellitus.

Typical fasting insulin levels found in this type of hyperinsulinism are above 20 μU/mL. When resistance is severe, levels can exceed 100 μU/mL.

In addition to being a risk factor for type 2 diabetes, hyperinsulinism due to insulin resistance may increase blood pressure and contribute to hypertension by direct action on vascular endothelial cells (the cells lining blood vessels). Hyperinsulinism has also been implicated as a contributing factor in the excessive production of androgens in polycystic ovary syndrome.

The principal treatments of hyperinsulinism due to insulin resistance are measures that improve insulin sensitivity, such as weight loss, physical exercise, and drugs such as thiazolidinediones or metformin.

Hyperinsulinism due to inappropriate secretion, associated with hypoglycemia

Hyperinsulinism is also used in medical contexts to refer to forms of hypoglycemia caused by excessive insulin secretion. In normal children and adults, insulin secretion should be minimal when blood glucose levels fall below 70 mg/dL (3.9 mM). There are many forms of hyperinsulinemic hypoglycemia caused by various types of insulin excess. Some of those that occur in infants and young children are termed congenital hyperinsulinism. In adults, severe hyperinsulinemic hypoglycemia is often due to an insulinoma, an insulin-secreting tumor of the pancreas.

Insulin levels above 3 μU/mL are inappropriate when the glucose level is below 50 mg/dL (2.8 mM), and may indicate hyperinsulinism as the cause of the hypoglycemia. The treatment of this form of hyperinsulinism depends on the cause and the severity of the hyperinsulinism, and may include surgical removal of the source of insulin, or a drug such as diazoxide or octreotide that reduces insulin secretion.

Dr. Seale Harris first diagnosed hyperinsulinism in 1924 [1] and also is credited with the recognition of spontaneous hypoglycemia.[2]

Hyperinsulinism due to insulin injection

The treatment of diabetes mellitus with insulin replacement therapy can easily result in diabetic hypoglycemia due to the difficulty of balancing insulin delivery.

Transient hyperinsulinism can also occur when insulin is injected by non-diabetic athletes attempting to enhance their anaerobic performance.


  1. "Restore Your Health Safely and Sensibly". Liteforlife.com. Retrieved 2007-02-24.
  2. "Seale Harris". Alabama State Archives. Retrieved 2007-02-24.